215 related articles for article (PubMed ID: 26971858)
21. Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques.
Shahabadi N; Khorshidi A; Moghadam NH
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():627-32. PubMed ID: 23811149
[TBL] [Abstract][Full Text] [Related]
22. Binding of wogonin to human serum albumin: a common binding site of wogonin in subdomain IIA.
Tian J; Liu J; Xie J; Yao X; Hu Z; Chen X
J Photochem Photobiol B; 2004 Mar; 74(1):39-45. PubMed ID: 15043845
[TBL] [Abstract][Full Text] [Related]
23. Interaction of anthracycline disaccharide with human serum albumin: investigation by fluorescence spectroscopic technique and modeling studies.
Cui F; Qin L; Zhang G; Liu Q; Yao X; Lei B
J Pharm Biomed Anal; 2008 Nov; 48(3):1029-36. PubMed ID: 18722067
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the interaction between nitrofurazone and human serum albumin by spectroscopic and molecular modeling methods.
Deng F; Dong C; Liu Y
Mol Biosyst; 2012 Apr; 8(5):1446-51. PubMed ID: 22337082
[TBL] [Abstract][Full Text] [Related]
25. Spectroscopic investigations on the binding of Pyronin Y to human serum albumin.
Salci A; Toprak M
J Biomol Struct Dyn; 2017 Jan; 35(1):8-16. PubMed ID: 26646531
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the interaction between human serum albumin and morin.
Xie MX; Long M; Liu Y; Qin C; Wang YD
Biochim Biophys Acta; 2006 Aug; 1760(8):1184-91. PubMed ID: 16750302
[TBL] [Abstract][Full Text] [Related]
27. Probing the interaction of a new synthesized CdTe quantum dots with human serum albumin and bovine serum albumin by spectroscopic methods.
Bardajee GR; Hooshyar Z
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():806-15. PubMed ID: 26952487
[TBL] [Abstract][Full Text] [Related]
28. Probing HSA-ionic liquid interactions by spectroscopic and molecular docking methods.
Kumari M; Maurya JK; Tasleem M; Singh P; Patel R
J Photochem Photobiol B; 2014 Sep; 138():27-35. PubMed ID: 24911269
[TBL] [Abstract][Full Text] [Related]
29. Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches.
Rehman MT; Shamsi H; Khan AU
Mol Pharm; 2014 Jun; 11(6):1785-97. PubMed ID: 24745377
[TBL] [Abstract][Full Text] [Related]
30. Study of the interaction between fisetin and human serum albumin: a biophysical approach.
Roy AS; Dinda AK; Dasgupta S
Protein Pept Lett; 2012 Jun; 19(6):604-15. PubMed ID: 22519532
[TBL] [Abstract][Full Text] [Related]
31. Interaction of meropenem with 'N' and 'B' isoforms of human serum albumin: a spectroscopic and molecular docking study.
Rehman MT; Ahmed S; Khan AU
J Biomol Struct Dyn; 2016 Sep; 34(9):1849-64. PubMed ID: 26372227
[TBL] [Abstract][Full Text] [Related]
32. Insights into in vitro binding of parecoxib to human serum albumin by spectroscopic methods.
Shang S; Liu Q; Gao J; Zhu Y; Liu J; Wang K; Shao W; Zhang S
J Biochem Mol Toxicol; 2014 Oct; 28(10):433-41. PubMed ID: 24939449
[TBL] [Abstract][Full Text] [Related]
33. Study of curcumin and genistein interactions with human serum albumin.
Mandeville JS; Froehlich E; Tajmir-Riahi HA
J Pharm Biomed Anal; 2009 Feb; 49(2):468-74. PubMed ID: 19135819
[TBL] [Abstract][Full Text] [Related]
34. Spectroscopic and molecular modeling approaches to investigate the binding of proton pump inhibitors to human serum albumin.
Pawar SK; Punith R; Naik RS; Seetharamappa J
J Biomol Struct Dyn; 2017 Nov; 35(15):3205-3220. PubMed ID: 27771990
[TBL] [Abstract][Full Text] [Related]
35. Interaction studies of aristolochic acid I with human serum albumin and the binding site of aristolochic acid I in subdomain IIA.
Wu X; Liu J; Huang H; Xue W; Yao X; Jin J
Int J Biol Macromol; 2011 Oct; 49(3):343-50. PubMed ID: 21635915
[TBL] [Abstract][Full Text] [Related]
36. Biophysical Study on the Interaction between Eperisone Hydrochloride and Human Serum Albumin Using Spectroscopic, Calorimetric, and Molecular Docking Analyses.
Rabbani G; Baig MH; Lee EJ; Cho WK; Ma JY; Choi I
Mol Pharm; 2017 May; 14(5):1656-1665. PubMed ID: 28380300
[TBL] [Abstract][Full Text] [Related]
37. Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy.
Dufour C; Dangles O
Biochim Biophys Acta; 2005 Jan; 1721(1-3):164-73. PubMed ID: 15652191
[TBL] [Abstract][Full Text] [Related]
38. Binding of paeonol to human serum albumin: a hybrid spectroscopic approach and conformational study.
Wang J
J Biochem Mol Toxicol; 2015 May; 29(5):213-20. PubMed ID: 25628233
[TBL] [Abstract][Full Text] [Related]
39. Probing the binding interaction of AKR with human serum albumin by multiple fluorescence spectroscopy and molecular modeling.
Li Y; Chen C; Zhang C; Duan J; Yao H; Wei Q
J Biomol Struct Dyn; 2017 May; 35(6):1189-1199. PubMed ID: 27050329
[TBL] [Abstract][Full Text] [Related]
40. Green synthesis of biogenic silver nanoparticles using Solanum tuberosum extract and their interaction with human serum albumin: Evidence of "corona" formation through a multi-spectroscopic and molecular docking analysis.
Ali MS; Altaf M; Al-Lohedan HA
J Photochem Photobiol B; 2017 Aug; 173():108-119. PubMed ID: 28570906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
